Condition 1: hot flush. Condition 2: anxiety. Menopausal and female climacteric states Anxiety disorder, unspecified
Conditions
Interventions
Intervention 1: The first Intervention group will receive oral capsules of curcumin twice a day at a dose of 500 milligrams for eight weeks. Intervention 2: The second intervention group will receive
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: Willingness to participate in the study Having sufficient literacy to complete the questionnaire or the presence of a literate person in the family Normal menopause Being married Women who have been under 6 years old since their menopause. Having at least 40 years and a maximum of 60 Having hot flush at least twice a week
Exclusion criteria
Exclusion criteria: Use of tobacco and alcoholic beverages and herbal medicines Stressful factors such as the death of relatives in the first six months of the past and loss of occupation Known psychiatric or systemic problems including cardiovascular, digestive, liver, endocrine, etc. Use of any effective medicines for hot flashes (Clonidine, Methyl dopa, Gabapentin, Selective Serotonin Reuptake Inhibitors (SSRIs), Norepinephrine inhibitors (SNRI), and Soy isoflavone Factors that cause vasomotor disorder, such as thyroid disease, according to the person expression Use of any effective medication to treat a person's sexual response (Antihypertensive, Thiazide diuretics, Antidepressant drugs such as Serotonin and Noradrenaline and Reuptake, Antihistamines, Barbiturates, Narcotics, Diazepam, Amphetamines, Cocaine History of allergy to turmeric or other drugs, food and color Taking anticoagulant drugs (Hyarin, Warfarin, Enoxaparin)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hot flush. Timepoint: Before the intervention, 4 and 8 weeks after the intervention. Method of measurement: Hot flush checklist.;Anxiety. Timepoint: Before the intervention, 4 and 8 weeks after the intervention. Method of measurement: State- Trait Anxiety Inventory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sexual function. Timepoint: Before the intervention, 4 and 8 weeks after the intervention. Method of measurement: FSFI= Female Sexual Function Inventory. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKhatereh Ataei
Tabriz University of Medical Sciences
Outcome results
None listed